ArticleGene therapy2001

Delivery of FGF-2 but not VEGF by encapsulated genetically engineered myoblasts improves survival and vascularization in a model of acute skin flap ischemia.

C Rinsch et al.PubMed ↗Publisher ↗

No numbers read from the abstract.